CALLAGHAN MICHAEL J 4
4 · CIPHERGEN BIOSYSTEMS INC · Filed Nov 28, 2003
Insider Transaction Report
Form 4
CALLAGHAN MICHAEL J
Director
Transactions
- Sale
Common Stock
2003-11-26$10.17/sh−3,000$30,516→ 17,000 total
Holdings
- 1,079,191(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The 3,000 shares were held for the benefit of The Health Care and Biotechnology Venture Fund. Michael Callaghan is an officer of MDS Capital Corp., the manager of The Health Care and Biotechnology Venture Fund. Mr. Callaghan disclaims beneficial ownership over these shares.
- [F2]1,079,191 common shares held by the following entities in the following respective amounts. Each of these entities disclaims beneficial ownership of the shares held by the other entities. Michael Callaghan disclaims beneficial ownership of these shares. 180,969 MDS Life Sciences Technology Fund USA, L.P. 132,826 MDS Life Sciences Technology Barbados Investment Trust 765,396 MDS Life Sciences Technology Fund Limited Partnership
- [F3]17,000 held by Mr. Callaghan for the benefit of the entities described in Footnote 2 above. Michael Callaghan disclaims beneficial ownership of all such shares.